Anti-PRAME Immunotherapeutic GSK2302032A

**Semantic type:** Pharmacologic Substance

**Definition:** An immunotherapeutic agent targeting the tumor-associated antigen (TAA), preferentially expressed antigen of melanoma (PRAME), with potential antineoplastic activity.

**Synonyms:** - GSK-2302032A - GSK2302032A - PRAME ASCI